156 related articles for article (PubMed ID: 9116581)
21. Association between I(2) binding sites and monoamine oxidase-B activity in platelets.
Zhu H; Piletz JE
Ann N Y Acad Sci; 2003 Dec; 1009():347-52. PubMed ID: 15028609
[TBL] [Abstract][Full Text] [Related]
22. Relationship between imidazoline(2) sites and monoamine oxidase.
Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610
[TBL] [Abstract][Full Text] [Related]
23. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
24. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A
J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297
[TBL] [Abstract][Full Text] [Related]
25. Characterization of [3H]idazoxan binding proteins in solubilized membranes from rabbit and human liver.
Remaury A; Missy K; Parini A
J Auton Nerv Syst; 1998 Oct; 72(2-3):111-7. PubMed ID: 9851559
[TBL] [Abstract][Full Text] [Related]
26. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
[TBL] [Abstract][Full Text] [Related]
27. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
King PR; Gundlach AL; Louis WJ
Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
[TBL] [Abstract][Full Text] [Related]
28. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
Holt A; Todd KG; Baker GB
Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
[TBL] [Abstract][Full Text] [Related]
29. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
30. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
Hosseini AR; King PR; Louis WJ; Gundlach AL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
[TBL] [Abstract][Full Text] [Related]
31. Localization of I2-imidazoline binding sites on monoamine oxidases.
Tesson F; Limon-Boulez I; Urban P; Puype M; Vandekerckhove J; Coupry I; Pompon D; Parini A
J Biol Chem; 1995 Apr; 270(17):9856-61. PubMed ID: 7730367
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of imidazoline I2 binding sites in pig brain.
Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
[TBL] [Abstract][Full Text] [Related]
33. Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites.
Sastre M; García-Sevilla JA
J Neurochem; 1993 Sep; 61(3):881-9. PubMed ID: 8395564
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney.
Limon I; Coupry I; Lanier SM; Parini A
J Biol Chem; 1992 Oct; 267(30):21645-9. PubMed ID: 1400475
[TBL] [Abstract][Full Text] [Related]
35. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice.
Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES
J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine.
Su RB; Li J; Li X; Qin BY
Acta Pharmacol Sin; 2001 Jul; 22(7):639-44. PubMed ID: 11749830
[TBL] [Abstract][Full Text] [Related]
37. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane.
Tesson F; Prip-Buus C; Lemoine A; Pegorier JP; Parini A
J Biol Chem; 1991 Jan; 266(1):155-60. PubMed ID: 1845963
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.
MacInnes N; Handley SL
Br J Pharmacol; 2002 Mar; 135(5):1227-34. PubMed ID: 11877331
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of imidazoline-binding sites from calf striatum.
Czerwiec E; De Backer JP; Flamez A; Vauquelin G
Eur J Pharmacol; 1996 Nov; 315(1):99-109. PubMed ID: 8960870
[TBL] [Abstract][Full Text] [Related]
40. Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor.
Parini A; Coupry I; Graham RM; Uzielli I; Atlas D; Lanier SM
J Biol Chem; 1989 Jul; 264(20):11874-8. PubMed ID: 2545687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
